Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

BK7508 Pharmaceutical Companies

Market Closed 05-22 16:00:00 AEST

420.83

+0.55

+0.13%

High424.82	Low416.34	Vol110.98M
Open421.27	D1 Closing420.29	Amplitude2.02%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O219.96M	T/O Rate--	Tradable Shares0.00
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":420.83435,"timestamp":1779429599957,"preClose":420.2878,"halted":0,"volume":110982454,"delay":0,"changeRate":0.0013,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":0.546539,"latestTime":"05-22 16:00:00 AEST","open":421.27005,"high":424.8237,"low":416.3442,"amount":219964711,"amplitude":0.020175,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1779667200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1779408000000,1779429600000]],"turnoverRate":0.004264,"increases":17,"decrements":7,"flats":19,"marketCap":57086726070.75,"floatMarketCap":54379601840.375},"requestUrl":"/m/hq/s/BK7508/wiki","defaultTab":"wiki","newsList":[{"id":"2637360942","title":"BUZZ-Australia's Mayne Pharma jumps after legal cost award","url":"https://stock-news.laohu8.com/highlight/detail?id=2637360942","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637360942?lang=en_us&edition=fundamental","pubTime":"2026-05-22 12:51","pubTimestamp":1779425506,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Mayne Pharma jumps after legal cost award** Mayne Pharma's MYX.AX shares jump as much as 8.1% to A$2.55, marking their biggest intraday gain since April 29, on track for a third strai","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nL6N41Z08R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637628443","title":"New South Wales Supreme Court Awards Mayne Pharma Group Over AU$13 Million in Legal Costs Following Cosette Pharmaceuticals Proceedings; Shares Up 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637628443","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637628443?lang=en_us&edition=fundamental","pubTime":"2026-05-22 11:09","pubTimestamp":1779419376,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  is entitled to nearly AU$13.3 million in legal costs following court proceedings against Cosette Pharmaceuticals in the New South Wales Supreme Court last year, according to a Friday filing with the Australian bourse.The company initiated proceedings against Cosette Pharmaceuticals in June 2025 in relation to Cosette's purported termination of the scheme implementation deed signed by the two parties in February 2025, the filing said.The court ruled in favor of the company in October 2025 and made an adverse costs order against Cosette, per the filing.Mayne Pharma Group shares rose 6% in midday trade on Friday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MYX.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637645073","title":"Imugene  Reports 81% Overall Response Rate in Azer-Cel Phase 1b Study, Shares Surge 22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637645073","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637645073?lang=en_us&edition=fundamental","pubTime":"2026-05-22 10:35","pubTimestamp":1779417331,"startTime":"0","endTime":"0","summary":"Imugene  said data from its azer-cel Phase 1b abstract, published on the American Society of Clinical Oncology  website, showed an overall response rate  of 81% among 16 evaluable patients, according to a Friday Australian bourse filing.The company said Azer-cel, an off-the-shelf allogeneic CAR T cell therapy targeting CD19 to treat blood cancers, showed responses across multiple lymphoma and leukemia subtypes, including a 60% response rate in diffuse large B-cell lymphoma  and a 100% response rate in marginal zone lymphoma .The company's shares rose 22% in recent Friday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMU.AU","BK7067","ORR","ORR.AU","BK7508","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637139346","title":"3 ASX Penny Stocks With Market Caps Over A$70M To Consider","url":"https://stock-news.laohu8.com/highlight/detail?id=2637139346","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637139346?lang=en_us&edition=fundamental","pubTime":"2026-05-22 10:09","pubTimestamp":1779415747,"startTime":"0","endTime":"0","summary":"It’s looking like we could be in for a green finish to the week with ASX futures tipping a rise of 0.5% for the ASX pre-market after oil prices dipped again overnight and gold travelled back above US$4,500 an ounce. While 'penny stocks' might seem like an outdated term, they continue to offer intriguing possibilities for investors seeking affordable entry points and growth potential. In this article, we highlight three penny stocks that showcase financial strength and resilience, offering...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/3071000-choice2-main-header/1585186751359","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3071000-choice2-main-header/1585186751359"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/capital-goods/asx-mxi/maxiparts-shares/news/3-asx-penny-stocks-with-market-caps-over-a70m-to-consider","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/capital-goods/asx-mxi/maxiparts-shares/news/3-asx-penny-stocks-with-market-caps-over-a70m-to-consider","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7096","BK7077","BK7508","MXI.AU","BK7062","CAF.AU","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637361551","title":"OncoSil Medical Says Encouraging Pancreatic Cancer Therapy Data to Be Presented at Chicago Conference; Shares Gain 13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637361551","media":"MT Newswires Live","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637361551?lang=en_us&edition=fundamental","pubTime":"2026-05-22 09:59","pubTimestamp":1779415192,"startTime":"0","endTime":"0","summary":"OncoSil Medical  said data highlighting the \"excellent safety\" of its OncoSil device for the treatment of pancreatic cancer will be presented at an American Society of Clinical Oncology conference in Chicago on May 30, according to a Friday filing with the Australian bourse.The data to be presented shows \"a high percentage of surgical resection rates\" achieved in locally advanced pancreatic cancer patients who were deemed unresectable at diagnosis, per the filing.The treatment with the OncoSil device showed a favorable safety profile and a median progression-free survival of 8.5 months, the company said.Shares of OncoSil Medical advanced nearly 13% in recent Friday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OSL.AU","BK7508","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637661653","title":"Mayne Pharma Group Ltd - Court Is Expected to Make Orders to Give Effect to Judgement Shortly","url":"https://stock-news.laohu8.com/highlight/detail?id=2637661653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637661653?lang=en_us&edition=fundamental","pubTime":"2026-05-22 09:08","pubTimestamp":1779412127,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nTUE6MPXLJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637366157","title":"Mayne Pharma Group Ltd - All Figures in AUD","url":"https://stock-news.laohu8.com/highlight/detail?id=2637366157","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637366157?lang=en_us&edition=fundamental","pubTime":"2026-05-22 09:08","pubTimestamp":1779412127,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nTUE6MPXLJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637393268","title":"ASX Runners of the Week: Hydrix, KTEK Aerosystems, AnteoTech & Castle","url":"https://stock-news.laohu8.com/highlight/detail?id=2637393268","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637393268?lang=en_us&edition=fundamental","pubTime":"2026-05-22 06:14","pubTimestamp":1779401669,"startTime":"0","endTime":"0","summary":"The Bulls N’ Bears ASX Runner of the Week is… Hydrix Limited, which surged after unveiling a strategic pivot into counter-drone defence technology through a deal with NIOA Group.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-22323588/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-22323588/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-hydrix-ktek-aerosystems-anteotech-castle-c-22323588","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-hydrix-ktek-aerosystems-anteotech-castle-c-22323588","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["ITA","DUST","FGDL","XME","DGP","BAR","HYD.AU","BTGD","GDX","GOLY","KTK.AU","DZZ","BK7501","CDT.AU","SHNY","BK7036","IAUM","RING","PICK","GDXU","GLL","PHYS","JDST","BK4535","UGL","SGOL","UYM","GLDM","IAU","DBC","IAUI","BK7048","GDXD","DULL","GOAU","CEF","USG","AAAU","GLTR","GDXY","BK7084","JNUG","BK4588","BK7508","GBUG","ADO.AU","GDXJ","OUNZ","SGDM","BEGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637735031","title":"ASX Penny Stocks With Market Caps Under A$2B","url":"https://stock-news.laohu8.com/highlight/detail?id=2637735031","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637735031?lang=en_us&edition=fundamental","pubTime":"2026-05-22 03:02","pubTimestamp":1779390146,"startTime":"0","endTime":"0","summary":"Australian shares are poised for a significant uptick, with futures indicating a 1% rise following optimistic developments in U.S.-Iran relations. In this context, penny stocks—though an older term—remain relevant as they often represent smaller or emerging companies that can offer unique investment opportunities. By focusing on those with strong financial health and potential for growth, investors may uncover promising options within this niche market segment.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/5121000-choice1-main-header/1585186829794","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5121000-choice1-main-header/1585186829794"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/food-beverage-tobacco/asx-ric/ridley-shares/news/asx-penny-stocks-with-market-caps-under-a2b","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/food-beverage-tobacco/asx-ric/ridley-shares/news/asx-penny-stocks-with-market-caps-under-a2b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","BK7036","ADO.AU","RIC.AU","BK7501","BK7048","BKY.AU","BK7083","BK7117"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637633278","title":"Asian Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2637633278","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637633278?lang=en_us&edition=fundamental","pubTime":"2026-05-21 22:41","pubTimestamp":1779374462,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were trending lower Thursday morning, declining 0.94% to 2,836.35 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by video display maker LG Display  and real estate and digital security company Eason Technology , which advanced 12% and 6.5% respectively. They were followed by semiconductor company Himax Technologies  and utilities company Korea Electric Power , which rose 2.5% and 1.2% respectively.The decliners from North Asia were led by internet and data center services provider VNET Group  and online entertainment company Bilibili , which dropped 5.5% and 4.4% respectively. They were followed by tech companies Alibaba Group  and Baidu , which lost 3.8% and 3.2% respectively.There were no gainers from South Asia.The decliners from South Asia were led by IT firm Infosys  and telecommunications operator Telekomunikasi Indonesia , which fell 3.8% and 2.8% respectively. They were followed by computer hard","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0251143458.SGD","BK4587","IE00B7N09G41.SGD","LU1003077747.HKD","LU1048596156.SGD","BK7096","BK4543","BK4510","LU1152091754.HKD","BABO","LU1051768304.USD","BK4563","LU1102505762.USD","BK4614","LU1366334651.USD","LU0640798160.USD","LU1515016050.SGD","LU0890818403.SGD","DXF","BK4085","LU0898667661.SGD","LU0708995666.HKD","LU0949170772.SGD","LU0880133367.SGD","IE00BF5LJ272.USD","LU0128525689.USD","BK4220","BK4089","LU0359202008.SGD","LU0868486357.SGD","BK4575","BK7502","BK4527","LU0651946864.USD","BK4505","BK4148","LU0348816934.USD","LU0501845795.SGD","LU0333810181.USD","BK4585","IE00B0JY6M65.USD","KEP","LU0797268264.HKD","BABU","BK4504","IE00B3M56506.USD","LU1105468828.SGD","BK4612","LU0067412154.USD","BK4141","LU0348744763.USD","LU0287143357.SGD","CAN","LU0328353924.USD","BK4509","LU1242518931.SGD","LU1046421795.USD","BK4503","LU1804176565.USD","LU1282648689.USD","BK4554","BK4523","BIDG","BK4518","BK4081","LU0106959298.USD","LU1242518857.USD","BK4170","LU0545039389.USD","LU2148611432.USD","LU0164881194.USD","LU1267930656.SGD","BK4524","BK4574","BK4533","BK4122","BK4164","BK4581","BK4595","09888","LU0831103253.SGD","BK4600","BK4566","BK4565","LU1688375341.USD","BIDU","LU1267930227.SGD","LU0918141887.USD","LU2663582299.SGD","LU1115378108.SGD","LU1051769294.HKD","IE00BYTNYM70.SGD","SIFY","LU0661504455.SGD","LU1823568750.SGD","BABX","LU1769817179.HKD","KBDU","LU2226246903.HKD","LU0310800965.SGD","LU1366334578.USD","TLK","BK4588","KBAB","LPL","BK4548","BBYY","BK7508","BILI","LU0052756011.USD","LU0047713382.USD","LU0541502299.USD","LU0918141705.HKD","BK4602","BK4534","INFY","LU2265009873.SGD","LU0348814723.USD","BK4117","BK4514","LU0738911758.USD","09988","LU0979878070.USD","LU0072462343.USD","BK4107","BK4538","LU0231203729.USD","LU2087589342.USD","BK4535","LU1023057109.AUD","LU0072913022.USD","LU1805238398.USD","LU0541501648.USD","LU1048588211.SGD","LU0821914370.USD","BK4502","BABA","LU0173614495.USD","LU0066902890.USD","LU1769817096.USD","LU1008478684.HKD","BK4577","HIMX","LU1235294995.USD","BK4531","LU0862451753.SGD","BK4077","09626","IE00BFMHRM44.USD","BK4526","BK4607","LU0431992006.USD","LU0553294199.USD","LU1046422090.SGD","LU0536402901.SGD","BABW","BK4558","LU0456842615.SGD","LU0359201612.USD","BK4579","LU0651947912.USD","BK4134","LU0791591158.USD","BK4552","LU0791590937.USD","LU0287142896.SGD","LU1880383366.USD","BK4115","BK4116","ALBmain","LU0531971678.HKD","LU1508157978.USD","BK4513","IE00B0JY6N72.USD","VNET","LU1152091168.USD","LU1323998911.USD","LU0197229882.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637333915","title":"Immutep executives face securities class action after ADRs plunge 83% on trial collapse","url":"https://stock-news.laohu8.com/highlight/detail?id=2637333915","media":"Reuters","labels":["executive","policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637333915?lang=en_us&edition=fundamental","pubTime":"2026-05-21 21:08","pubTimestamp":1779368914,"startTime":"0","endTime":"0","summary":"Immutep faces a securities class action tied to investor purchases from March 24, 2025 to March 12, 2026, centered on the collapse of the TACTI-004 trial.ADRs fell to $0.48 from $2.76 on March 13, 2026, a one-day drop of 83% that erased $2.28 per share.The suit names CEO Marc Voigt, Chief Scientific Officer Frédéric Triebel, and Chief Medical Officer Stephan Winckels as individual defendants under Section 20 control-person claims.Plaintiffs allege the executives misled investors about trial progress while holding adverse non-public interim data, including through Sarbanes-Oxley certifications tied to SEC filings.A court deadline of July 6, 2026 has been set for investors seeking appointment as lead plaintiff.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL3s7WXt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Immutep executives face securities class action after ADRs plunge 83% on trial collapse","news_tag":"executive,policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","IMM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637383248","title":"Canaan (CAN) Q1 2026 Heavy Losses Challenge Bullish Revenue Growth Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2637383248","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637383248?lang=en_us&edition=fundamental","pubTime":"2026-05-21 15:26","pubTimestamp":1779348378,"startTime":"0","endTime":"0","summary":"Canaan (NasdaqGM:CAN) has just posted its Q1 2026 numbers, with revenue of about US$62.7 million and a basic EPS loss of US$0.13, while trailing twelve month revenue sits at roughly US$509.7 million and TTM EPS is a loss of US$0.38. Over recent quarters the company has seen revenue move from US$82.8 million in Q1 2025 to US$100.2 million in Q2, US$150.5 million in Q3 and US$196.3 million in Q4. Over the same period, EPS losses shifted from US$0.27 to US$0.03, US$0.05 and US$0.13 respectively...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9621091-choice1-main-header/1585186722323","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9621091-choice1-main-header/1585186722323"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/tech/nasdaq-can/canaan/news/canaan-can-q1-2026-heavy-losses-challenge-bullish-revenue-gr","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/tech/nasdaq-can/canaan/news/canaan-can-q1-2026-heavy-losses-challenge-bullish-revenue-gr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4526","BK7096","CAN","BK4170","BK7508","BLSG","BK4600","BK4112","BK4595","BK7502","BLSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637275390","title":"OSL Strengthens Asia’s Digital Asset Ecosystem with Listing of State-Supervised Gold-Backed Stablecoin USDKG","url":"https://stock-news.laohu8.com/highlight/detail?id=2637275390","media":"utoday","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637275390?lang=en_us&edition=fundamental","pubTime":"2026-05-21 10:14","pubTimestamp":1779329640,"startTime":"0","endTime":"0","summary":"Hong Kong, Hong Kong, May 21st, 2026, ChainwireOSL Group (863.HK) (OSL), a global stablecoin payment and trading platform, today announced that its Hong Kong-licensed digital asset exchange OSL HK has","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"utodaynews_highlight","url":"https://u.today/press-releases/osl-strengthens-asias-digital-asset-ecosystem-with-listing-of-state-supervised-gold","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://u.today/press-releases/osl-strengthens-asias-digital-asset-ecosystem-with-listing-of-state-supervised-gold","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"utodaynews_highlight","symbols":["BEGS","LU0106831901.USD","IE00B3QW5Z07.USD","BK4135","LU1894683348.USD","CCUP","LU1668664300.SGD","IE0034235188.USD","BK7048","OSL.AU","LU1883839398.USD","CRCD","LU2360107671.USD","STT","LU1861558580.USD","LU0061475181.USD","LU1861217088.USD","BK4585","IE00BGHQF748.EUR","BK7508","LU1894683264.USD","CRCL","CRCO","LU1861220207.SGD","CRCA","BK4588","IE00B64PRP62.GBP","ICRC","LU1791807156.HKD","BK4023","LU1861559042.SGD","CRCG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637714988","title":"Racura Oncology Ltd-Racura Oncology Final Option Expiry Reminder","url":"https://stock-news.laohu8.com/highlight/detail?id=2637714988","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637714988?lang=en_us&edition=fundamental","pubTime":"2026-05-21 07:34","pubTimestamp":1779320069,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUE8VM2RD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","RAC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637871467","title":"Imricor Medical Systems Inc-Update - Notification Regarding Unquoted Securities - Imr","url":"https://stock-news.laohu8.com/highlight/detail?id=2637871467","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637871467?lang=en_us&edition=fundamental","pubTime":"2026-05-21 07:33","pubTimestamp":1779320022,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUEBHFCQD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7503","BK7007","IMR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636811825","title":"Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2636811825","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636811825?lang=en_us&edition=fundamental","pubTime":"2026-05-20 22:35","pubTimestamp":1779287723,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were tracking higher Wednesday morning, rising 0.63% to 2,846.43 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by real estate and digital security company Eason Technology  and mobile big data provider Aurora Mobile , which advanced 10% and 1.9% respectively. They were followed by solar panel maker JinkoSolar  and fintech firm LexinFintech , which increased 1.7% and 1.2% respectively.The decliners from North Asia were led by online entertainment platform Bilibili  and utilities company Korea Electric Power , which fell 6.2% and 5.3% respectively. They were followed by automotive marketplaces Token Cat  and Autohome , which were down 5% and 2.3% respectively.From South Asia, the gainers were led by computer hardware maker Canaan  and telecommunications operator Telekomunikasi Indonesia , which rose 5.2% and 1.5% respectively. They were followed by lender ICICI Bank  and IT firm Sify Technologies , which","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0541502299.USD","SG9999014484.SGD","LU0287143357.SGD","LU0499858438.USD","LU0197229882.USD","BK4513","LU0048573645.USD","LU0348744763.USD","SG9999014492.USD","BK4588","SG9999002414.USD","BK4089","IE00B7N09G41.SGD","SG9999002620.SGD","BK4503","LU0066902890.USD","BK7508","LU2045819591.USD","BK4554","BK4141","LU0048575426.USD","BK4531","LU2125910849.SGD","LU0516423091.SGD","BK4107","BK4166","BK4009","BK4207","LU0049112450.USD","LU0431992006.USD","LU0441851309.USD","LU0532188223.SGD","LU0821914370.USD","LU1770036033.HKD","LU2065170008.USD","LU2663582299.SGD","LU1366334651.USD","SGXZ58947870.SGD","LU0516422366.SGD","LU2125910500.SGD","LU0979878070.USD","BK4523","BK4551","LU0248272758.USD","BK4023","IE00B3M56506.USD","BK4585","LU2360107671.USD","LU0831103253.SGD","LU0289960550.SGD","LU1235295612.USD","LU0890818403.SGD","AIA","LU2065171402.SGD","BK4134","BK7502","LU0143863198.USD","SG9999001135.SGD","LU0333810181.USD","BK4535","LU0261945553.USD","BK4115","LU1102505929.USD","LU0164881194.USD","BK4600","LU1868837722.USD","BK4117","LU0307460401.USD","BK4164","LU0143863784.USD","LU2152927971.USD","IE0001KFT4U8.USD","BK4587","BK4579","LU2778985437.USD","LU1861217088.USD","LU0823038988.USD","SG9999013478.USD","LU2177674079.SGD","LU0251143029.SGD","BK4081","SG9999006266.SGD","LU1048596156.SGD","LU0868486357.SGD","LU0345776255.USD","SG9999002406.SGD","LU0516422440.USD","BK4563","LU0181495838.USD","LU0572940350.SGD","LU1242518857.USD","LU0862451753.SGD","LU1046422090.SGD","LU0210637038.USD","LU0791591158.USD","LU1267930656.SGD","LU1839390173.USD","LU1805238398.USD","LU2087589342.USD","LU0348788117.USD","LU2008162690.USD","LU0264606111.USD","LU1048588211.SGD","BK4566","LU0531971678.HKD","LU0823039010.USD","LU0499858602.USD","LU0708995666.HKD","LU0231203729.USD","LU1481012133.USD","BK4077","BK4581","LU1242518931.SGD","LU0516422952.EUR","BK7096","LU1102505762.USD","LU0541501648.USD","IE0034224299.USD","BK4510","LU0251143458.SGD","LU0589944569.HKD","SG9999013460.SGD","LU0572939691.SGD","LU1508157978.USD","IE00B0JY6M65.USD","LU0791590937.USD","LU0516423174.USD","BK4085","BK4548","LU0261950470.USD","LU2476274308.USD","LU2265009873.SGD","SG9999004220.SGD","IE00BD6J9T35.USD","BK4595","LU1861220207.SGD","LU2543165471.USD","SG9999005177.SGD","BK4533","LU1323998911.USD","LU2238330802.EUR","SG9999013486.USD","LU0898667661.SGD","BK4519","LU0264410563.USD","BK4220","BK4132","BK4576","IE00BYTNYM70.SGD","LU1868838027.USD","SG9999002679.SGD","LU1804176565.USD","SG9999002604.SGD","LU1868837565.USD","LU0072462343.USD","LU0345775950.USD","LU0536402901.SGD","BK4509","LU0828237940.HKD","BK4577","LU1366334578.USD","BK4504","BK4526","BK4505","SG9999004360.SGD","IE0031814969.USD","LU0737861269.HKD","LU2065169927.USD","BK4170","LU2065171311.SGD","LU0175139822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636828748","title":"The Bull Case For CSL (ASX:CSL) Could Change Following Canadian HEMGENIX Reimbursement Milestone – Learn Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2636828748","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636828748?lang=en_us&edition=fundamental","pubTime":"2026-05-20 21:45","pubTimestamp":1779284704,"startTime":"0","endTime":"0","summary":"CSL recently reported that its first Canadian patient has received HEMGENIX® for hemophilia B at London Health Sciences Centre, following public reimbursement agreements that now provide access in Ontario and British Columbia while other provinces review coverage.\nThis early real-world use of HEMGENIX® under public funding in Canada highlights how CSL’s high-value gene therapy portfolio is beginning to translate into tangible patient access and market uptake.\nNext, we’ll examine how this...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/the-bull-case-for-csl-asxcsl-could-change-following-canadian","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/the-bull-case-for-csl-asxcsl-could-change-following-canadian","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7511","BK4585","SG9999004303.SGD","AIYY","LU1169590202.USD","AGIX","BK4587","AI","ARTY","BK4551","SGXZ23171101.USD","BK4086","LU0728928796.USD","BK7067","BK4588","BK7508","AIPO","CHAT","BK7501","BK4023","CSL","LU1169589451.USD","BK4528","CSL.AU","BK4543"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636845972","title":"CSL Canada administers first HEMGENIX gene therapy dose to Canadian patient","url":"https://stock-news.laohu8.com/highlight/detail?id=2636845972","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636845972?lang=en_us&edition=fundamental","pubTime":"2026-05-20 18:26","pubTimestamp":1779272807,"startTime":"0","endTime":"0","summary":"CSL’s unit CSL Canada administered HEMGENIX, its one-time hemophilia B gene therapy, to the first Canadian patient outside a clinical trial at London Health Sciences Centre in Ontario.Public reimbursement is now in place in Ontario and British Columbia following a pan-Canadian Pharmaceutical Alliance agreement, using the provinces’ exceptional access pathways.The treatment is indicated in Canada for adults with hemophilia B who require routine prophylaxis, with no clinical experience cited for mild or moderate disease with Factor IX activity above 2%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CSL Limited published the original content used to generate this news brief on May 20, 2026, and is solely responsible for the information c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL7HzQ9r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","CSL.AU","BK7508","BK7511","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636848079","title":"CSL Canada Announces First Canadian Patient Receives Hemgenix® (Etranacogene Dezaparvovec) Hemophilia B Gene Therapy in Ontario, Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2636848079","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636848079?lang=en_us&edition=fundamental","pubTime":"2026-05-20 18:00","pubTimestamp":1779271208,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUA7VKBHG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7501","CSL.AU","BK7511","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636813105","title":"BRIEF-Oncosil Medical Receives TGA Approval In Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2636813105","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636813105?lang=en_us&edition=fundamental","pubTime":"2026-05-20 14:07","pubTimestamp":1779257233,"startTime":"0","endTime":"0","summary":"BRIEF-Oncosil Medical Receives TGA Approval In AustraliaMay 20 (Reuters) - Oncosil Medical Ltd OSL.AX:ONCOSIL MEDICAL RECEIVES TGA APPROVAL IN AUSTRALIARECEIVES TGA APPROVAL FOR ONCOSIL DEVICE FOR PANCREATIC CANCER IN AUSTRALIAFurther company coverage: OSL.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nFWN41W0UW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","OSL.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0331},{"period":"1month","weight":0.002},{"period":"3month","weight":-0.019},{"period":"6month","weight":0.0463},{"period":"1year","weight":0.1094},{"period":"ytd","weight":0.0021}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"name":"BK7508","nameEN":"BK7508"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharmaceutical Companies(BK7508) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharmaceutical Companies,BK7508,Pharmaceutical Companies股票,Pharmaceutical Companies股票老虎,Pharmaceutical Companies股票老虎国际,Pharmaceutical Companies行情,Pharmaceutical Companies股票行情,Pharmaceutical Companies股价,Pharmaceutical Companies股市,Pharmaceutical Companies股票价格,Pharmaceutical Companies股票交易,Pharmaceutical Companies股票购买,Pharmaceutical Companies股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharmaceutical Companies(BK7508) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction